COVID 19 – Pfizer for Kids Vaccine Information

Pfizer for Kids Vaccine

On 5 December 2021, the Therapeutic Goods Administration (TGA) provisionally approved the Comirnaty (Pfizer) vaccine for children aged 5 to 11 years. The TGA’s provisional approval of Pfizer for children was based on a careful evaluation of available data to support its safety and efficacy among this age group.
Vaccinating children can help protect children from getting COVID-19. It can also help prevent children passing the virus onto younger siblings, parents, grandparents and the wider community.
Children aged 5 to 11 years will receive a 2-dose primary course of vaccination, given 8 weeks apart.

Parents, carers and guardians can book appointments through the Vaccine Clinic Finder, with appointments starting from 10 January 2022. If you can’t find an appropriate appointment, please check back regularly as more appointments will become available.

Common side effects

As with any vaccine, you may have some temporary side effects after receiving Pfizer. This shows your immune system is working. Common side effects after Pfizer include:

Rare side effects

In rare cases, myocarditis (inflammation of the heart) and pericarditis (inflammation of the membrane around the heart) can develop after vaccination with Pfizer. Most cases have mild symptoms and recover well.
The TGA reports that these rare effects on the heart typically occur:
Contact a doctor or go to hospital immediately if you develop any of the following symptoms after a Pfizer vaccination: